evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract,articles/19/pmid,articles/19/title,articles/19/journal,articles/19/pubDate,articles/19/volume,articles/19/issue,articles/19/pages,articles/19/authors,articles/19/elocationId,articles/19/link,articles/19/reference,articles/19/abstract,articles/20/pmid,articles/20/title,articles/20/journal,articles/20/pubDate,articles/20/volume,articles/20/issue,articles/20/pages,articles/20/authors,articles/20/elocationId,articles/20/link,articles/20/reference,articles/20/abstract,articles/21/pmid,articles/21/title,articles/21/journal,articles/21/pubDate,articles/21/volume,articles/21/issue,articles/21/pages,articles/21/authors,articles/21/elocationId,articles/21/link,articles/21/reference,articles/21/abstract
4256,GENE_SUMMARY,,"PDGFRA, a receptor tyrosine kinase, is altered by mutation, chromosomal rearrangement or amplifications in a diverse range of cancers.",,2017-04-24,,5156,PDGFRA,platelet derived growth factor receptor alpha,True,ENST00000257290,NM_006206.4,PDGFR2,RHEPDGFRA,GAS9,PDGFR-2,CD140A,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4257,GENE_BACKGROUND,,"The PDGFRA gene encodes for the protein Platelet-derived growth factor alpha (PDGFRA). Binding of ligand to the extracellular domain of PDGFRA, which contains immunoglobulin (Ig)-like domains, causes dimerization followed by autophosphorylation of the receptor and activation of downstream pathways such as RAS-MAPK, PI3K and PLC-γ that are involved in developmental and cellular responses. The catalytic activity of PDGFRA is mediated through the split intracellular tyrosine kinase domain; PDGFRA binds to all PDGF ligand isoforms except PDGF-DD (PMID:18483217, 24703957). Mutations, insertions, deletions, fusions and genomic amplification of PDGFRA lead to its activation in several tumor types: ~7% of gastrointestinal stromal tumors (GISTs) have PDGFRA activating mutations and these mutations are mutually exclusive from KIT mutations (PMID: 20023271); activating mutations in PDGFRA have been been reported in ~5% of Chinese melanoma patients (PMID:24132921); amplification of PDGFRA is the second most frequent receptor tyrosine kinase amplification in glioblastoma (GBM), is found in ~7-15% of GBM tumors and is often associated with in-frame deletions (PMID:18772890,19915670, 22323597, 20129251, 20889717); amplification of the PDGFRA locus has been reported in more than 80% of intimal sarcomas (PMID:20685895), ~19% of malignant peripheral nerve sheath tumors (PMID:16357008), 3–7% of non-small cell lung adenocarcinomas and 8–10% non-small cell lung squamous cell carcinomas (PMID:19755855); activating mutations have been found in ~5% of diffuse intrinsic pontine gliomas and in ~14% of non-brain stem pediatric high-grade gliomas, around 40% of these occurring in the context of PDGFRA amplification (PMID:23970477); chimeric fusion transcripts to the catalytic domain of PDGFRA have been reported in select cases of GBM (PMID:20889717), chronic myeloid leukemia (PMID:12023981,12944919, 15034867) and hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL) (PMID:12660384, 19187542, 16498388, 16845659, 17555450). PDGFRA mutations have also been reported in inflammatory fibroid polyps (PMID: 22394371), and these mutations have been characterized as activating in other disease types.",,2017-08-07,,5156,PDGFRA,platelet derived growth factor receptor alpha,True,ENST00000257290,NM_006206.4,PDGFR2,RHEPDGFRA,GAS9,PDGFR-2,CD140A,False,17555450,Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia.,British journal of haematology,2018-07-01T20:07:00,138,True,77-81,Curtis CE et al,,,0001-07-01,,20889717,PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.,Genes &amp; development,2018-10-01T20:10:00,24,19,2205-18,Ozawa T et al,doi: 10.1101/gad.1972310,,0001-10-01,,15034867,Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.,"Genes, chromosomes &amp; cancer",2018-05-01T20:04:00,40,True,44-50,Safley AM et al,,,0001-05-01,,12660384,A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.,The New England journal of medicine,2018-03-27T20:03:00,348,13,1201-14,Cools J et al,,,0001-03-27,,12944919,Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec.,Oncogene,2018-08-28T20:03:00,22,36,5702-6,Trempat P et al,,,0001-08-28,,16845659,Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.,"Genes, chromosomes &amp; cancer",2018-10-01T20:06:00,45,10,950-6,Walz C et al,,,0001-10-01,,18772890,Comprehensive genomic characterization defines human glioblastoma genes and core pathways.,Nature,2018-10-23T20:08:00,455,7216,1061-8,Cancer Genome Atlas Research Network.,doi: 10.1038/nature07385,,0001-10-23,,20129251,"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.",Cancer cell,2018-01-19T20:10:00,17,True,98-110,Verhaak RG et al,doi: 10.1016/j.ccr.2009.12.020,,2018-01-19T01:10:00,,16498388,Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia.,Leukemia,2018-05-01T20:06:00,20,5,827-32,Score J et al,,,0001-05-01,,18483217,Role of platelet-derived growth factors in physiology and medicine.,Genes &amp; development,2018-05-15T20:08:00,22,10,1276-312,Andrae J et al,doi: 10.1101/gad.1653708,,2018-05-15T03:12:00,,24132921,Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.,Clinical cancer research : an official journal of the American Association for Cancer Research,2017-12-15T20:13:00,19,24,6935-42,Dai J et al,doi: 10.1158/1078-0432.CCR-13-1266,,0001-12-15,,22394371,"Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localization.",Histopathology,2018-07-01T20:12:00,61,True,59-68,Huss S et al,doi: 10.1111/j.1365-2559.2012.04203.x,,0001-07-01,,23970477,Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.,Cancer research,2018-10-15T20:13:00,73,20,6219-29,Paugh BS et al,doi: 10.1158/0008-5472.CAN-13-1491,,0001-10-15,,19915670,Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.,PloS one,2018-11-13T20:09:00,4,11,e7752,Brennan C et al,doi: 10.1371/journal.pone.0007752,,0001-11-13,,19755855,Amplification of chromosomal segment 4q12 in non-small cell lung cancer.,Cancer biology &amp; therapy,2018-11-01T20:09:00,8,21,2042-50,Ramos AH et al,,,0001-11-01,,12023981,The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.,Human molecular genetics,2018-06-01T20:02:00,11,12,1391-7,Baxter EJ et al,,,0001-06-01,,22323597,Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.,Proceedings of the National Academy of Sciences of the United States of America,2018-02-21T20:12:00,109,8,3041-6,Szerlip NJ et al,doi: 10.1073/pnas.1114033109,,0001-02-21,,16357008,"Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.",Carcinogenesis,2018-03-01T20:06:00,27,3,664-71,Holtkamp N et al,,,0001-03-01,,20023271,Detection of c-KIT and PDGFRA gene mutations in gastrointestinal stromal tumors: comparison of DHPLC and DNA sequencing methods using a single population-based cohort.,American journal of clinical pathology,2018-01-01T20:10:00,133,True,149-55,Battochio A et al,doi: 10.1309/AJCP1FNW7RGZFTYU,,0001-01-01,,19187542,FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia.,BMC blood disorders,2018-02-02T20:09:00,9,,True,Loules G et al,2326-09-01,,0001-02-02,,24703957,PDGF receptor signaling networks in normal and cancer cells.,Cytokine &amp; growth factor reviews,2018-06-01T20:14:00,25,3,273-83,Demoulin JB et al,doi: 10.1016/j.cytogfr.2014.03.003,,0001-06-01,,20685895,Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma.,Cancer research,2018-09-15T20:10:00,70,18,7304-14,Dewaele B et al,doi: 10.1158/0008-5472.CAN-10-1543,,0001-09-15,
